Cargando…

Study of ExacTrac X‐ray 6D IGRT setup uncertainty for marker‐based prostate IMRT treatment

Novalis Tx ExacTrac X‐ray system has the 6D adjustment ability for patient setup. Limited studies exist about the setup uncertainty with ExacTrac X‐ray system for IMRT prostate treatment with fiducial markers implanted. The purpose of this study is to investigate the marker‐based prostate IMRT treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Chengyu, Tazi, Adam, Fang, Deborah Xiangdong, Iannuzzi, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716561/
https://www.ncbi.nlm.nih.gov/pubmed/22584176
http://dx.doi.org/10.1120/jacmp.v13i3.3757
_version_ 1783283972925554688
author Shi, Chengyu
Tazi, Adam
Fang, Deborah Xiangdong
Iannuzzi, Christopher
author_facet Shi, Chengyu
Tazi, Adam
Fang, Deborah Xiangdong
Iannuzzi, Christopher
author_sort Shi, Chengyu
collection PubMed
description Novalis Tx ExacTrac X‐ray system has the 6D adjustment ability for patient setup. Limited studies exist about the setup uncertainty with ExacTrac X‐ray system for IMRT prostate treatment with fiducial markers implanted. The purpose of this study is to investigate the marker‐based prostate IMRT treatment setup uncertainty using ExacTrac 6D IGRT ability for patient setup. Forty‐three patients with prostate cancers and markers implanted have been treated on the Novalis Tx machine. The ExacTrac X‐ray system has been used for the patient pretreatment setup and intratreatment verification. In total, the shifts data for 1261 fractions and 3504 correction times (the numbers of X‐ray images were taken from tube 1 and tube 2) have been analyzed. The setup uncertainty has been separated into uncertainties in 6D. Marker matching uncertainty was also analyzed. Correction frequency probability density function was plotted, and the radiation dose for imaging was calculated. The minimum, average, and maximum translation shifts were: [Formula: see text] , [Formula: see text] , and [Formula: see text] , respectively, in the lateral direction; [Formula: see text] , [Formula: see text] , and [Formula: see text] , respectively, in the longitudinal direction; and [Formula: see text] , [Formula: see text] , and [Formula: see text] , respectively, in the vertical direction. The minimum, average, and maximum rotation shifts were: [Formula: see text] , [Formula: see text] , and [Formula: see text] , respectively, along lateral direction; [Formula: see text] , [Formula: see text] , and [Formula: see text] , respectively, along longitudinal direction; and [Formula: see text] , [Formula: see text] , and [Formula: see text] , respectively, along vertical direction. On average, each patient had three correction times during one fraction treatment. The radiation dose is about 3 mSv per fraction. With the ExacTrac 6D X‐ray system, the prostate IMRT treatment with marker implanted can achieve less than 2 mm setup uncertainty in translations, and less than 0.25° in rotations as overall interfraction mean error. The imaging dose is less than kV (CBCT) for setup verification. PACS number: 87.55.km, 87.55.Qr, 87.56.bd
format Online
Article
Text
id pubmed-5716561
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57165612018-04-02 Study of ExacTrac X‐ray 6D IGRT setup uncertainty for marker‐based prostate IMRT treatment Shi, Chengyu Tazi, Adam Fang, Deborah Xiangdong Iannuzzi, Christopher J Appl Clin Med Phys Radiation Oncology Physics Novalis Tx ExacTrac X‐ray system has the 6D adjustment ability for patient setup. Limited studies exist about the setup uncertainty with ExacTrac X‐ray system for IMRT prostate treatment with fiducial markers implanted. The purpose of this study is to investigate the marker‐based prostate IMRT treatment setup uncertainty using ExacTrac 6D IGRT ability for patient setup. Forty‐three patients with prostate cancers and markers implanted have been treated on the Novalis Tx machine. The ExacTrac X‐ray system has been used for the patient pretreatment setup and intratreatment verification. In total, the shifts data for 1261 fractions and 3504 correction times (the numbers of X‐ray images were taken from tube 1 and tube 2) have been analyzed. The setup uncertainty has been separated into uncertainties in 6D. Marker matching uncertainty was also analyzed. Correction frequency probability density function was plotted, and the radiation dose for imaging was calculated. The minimum, average, and maximum translation shifts were: [Formula: see text] , [Formula: see text] , and [Formula: see text] , respectively, in the lateral direction; [Formula: see text] , [Formula: see text] , and [Formula: see text] , respectively, in the longitudinal direction; and [Formula: see text] , [Formula: see text] , and [Formula: see text] , respectively, in the vertical direction. The minimum, average, and maximum rotation shifts were: [Formula: see text] , [Formula: see text] , and [Formula: see text] , respectively, along lateral direction; [Formula: see text] , [Formula: see text] , and [Formula: see text] , respectively, along longitudinal direction; and [Formula: see text] , [Formula: see text] , and [Formula: see text] , respectively, along vertical direction. On average, each patient had three correction times during one fraction treatment. The radiation dose is about 3 mSv per fraction. With the ExacTrac 6D X‐ray system, the prostate IMRT treatment with marker implanted can achieve less than 2 mm setup uncertainty in translations, and less than 0.25° in rotations as overall interfraction mean error. The imaging dose is less than kV (CBCT) for setup verification. PACS number: 87.55.km, 87.55.Qr, 87.56.bd John Wiley and Sons Inc. 2012-05-10 /pmc/articles/PMC5716561/ /pubmed/22584176 http://dx.doi.org/10.1120/jacmp.v13i3.3757 Text en © 2012 The Authors. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Shi, Chengyu
Tazi, Adam
Fang, Deborah Xiangdong
Iannuzzi, Christopher
Study of ExacTrac X‐ray 6D IGRT setup uncertainty for marker‐based prostate IMRT treatment
title Study of ExacTrac X‐ray 6D IGRT setup uncertainty for marker‐based prostate IMRT treatment
title_full Study of ExacTrac X‐ray 6D IGRT setup uncertainty for marker‐based prostate IMRT treatment
title_fullStr Study of ExacTrac X‐ray 6D IGRT setup uncertainty for marker‐based prostate IMRT treatment
title_full_unstemmed Study of ExacTrac X‐ray 6D IGRT setup uncertainty for marker‐based prostate IMRT treatment
title_short Study of ExacTrac X‐ray 6D IGRT setup uncertainty for marker‐based prostate IMRT treatment
title_sort study of exactrac x‐ray 6d igrt setup uncertainty for marker‐based prostate imrt treatment
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716561/
https://www.ncbi.nlm.nih.gov/pubmed/22584176
http://dx.doi.org/10.1120/jacmp.v13i3.3757
work_keys_str_mv AT shichengyu studyofexactracxray6digrtsetupuncertaintyformarkerbasedprostateimrttreatment
AT taziadam studyofexactracxray6digrtsetupuncertaintyformarkerbasedprostateimrttreatment
AT fangdeborahxiangdong studyofexactracxray6digrtsetupuncertaintyformarkerbasedprostateimrttreatment
AT iannuzzichristopher studyofexactracxray6digrtsetupuncertaintyformarkerbasedprostateimrttreatment